{"id":100843,"date":"2021-01-21T19:10:00","date_gmt":"2021-01-21T19:10:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2811025"},"modified":"2021-01-21T19:10:00","modified_gmt":"2021-01-21T19:10:00","slug":"the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/","title":{"rendered":"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis"},"content":{"rendered":"<p><a href=\"https:\/\/icrowdnewswire.com\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#\" class=\"icrowd_post_img\"> <!--<img decoding=\"async\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png\" alt=\"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis\">--> <img decoding=\"async\" width=\"96\" height=\"96\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png\" class=\"attachment-thumbnail size-thumbnail wp-post-image\" alt=\"The global preventiv\" loading=\"lazy\"> <\/a> <\/p>\n<p><strong>iCrowdNewswire <\/strong><span class=\"date\">&nbsp;&nbsp;Jan 21, 2021&nbsp;&nbsp;2:10 PM ET<\/span><\/p>\n<p><em>Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list<\/em><\/p>\n<p><a href=\"https:\/\/www.rootsanalysis.com\/\">Roots Analysis<\/a> is pleased to announce the publication of its recent study, titled, \u201c<a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/preventive-vaccines\/318.html\">Global Preventive Vaccines Market, 2020-2030<\/a>\u201d.<\/p>\n<p>The report features an extensive study of the current market landscape and future opportunities associated with the preventive vaccine domain. The study also features a detailed analysis of the key drivers and trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:<\/p>\n<ul>\n<li>A detailed assessment of the current market landscape, featuring clinical-stage preventive vaccines.<\/li>\n<li>A competitiveness analysis of preventive vaccine developers, featuring insightful pictorial summaries and representations.<\/li>\n<li>Elaborate profiles of the key preventive vaccine developers (shortlisted based on a proprietary criterion) across North America, Europe and Asia Pacific.<\/li>\n<li>An in-depth analysis of the completed, ongoing and planned trials of various preventive vaccines<em>.<\/em><\/li>\n<li>An overview of the ongoing vaccine development initiatives for complex conditions, such as COVID-19, Ebola virus disease, HIV\/AIDS, malaria and zika virus infection.<\/li>\n<li>An analysis of the investments made in this domain, during the period between 2015 and 2020 (<em>till March<\/em>).<\/li>\n<li>A case study on contract manufacturing landscape for vaccines, featuring the CMOs engaged in this domain.<\/li>\n<li>A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)\n<ul>\n<li>Route of Administration<\/li>\n<\/ul>\n<\/li>\n<li>Intramuscular<\/li>\n<li>Subcutaneous<\/li>\n<li>Oral<\/li>\n<li>Intravenous<\/li>\n<li>Others<\/li>\n<li>Type of Vaccine<\/li>\n<li>Pneumococcal Conjugate Vaccine<\/li>\n<li>Human Papilloma Virus Vaccine<\/li>\n<li>Rotavirus Vaccine<\/li>\n<li>Influenza Vaccine<\/li>\n<li>MMR Vaccine<\/li>\n<li>Tetanus and Diphtheria Booster Vaccine<\/li>\n<li>Varicella Vaccine<\/li>\n<li>DTaP-Hib-IPV Vaccine<\/li>\n<li>DTaP-HepB-Hib-IPV Vaccine<\/li>\n<li>Others<\/li>\n<li>Type of Vaccine API<\/li>\n<li>Live, Attenuated Vaccine<\/li>\n<li>Inactivated Vaccine<\/li>\n<li>Conjugate Vaccine<\/li>\n<li>Subunit Vaccine<\/li>\n<li>Toxoid Vaccine<\/li>\n<li>Others\n<ul>\n<li>Target Patient Population<\/li>\n<\/ul>\n<\/li>\n<li>Pediatric Patients<\/li>\n<li>Adults<\/li>\n<li>Key Players<\/li>\n<li>GlaxoSmithKline<\/li>\n<li>Merck<\/li>\n<li>Sanofi Pasteur<\/li>\n<li>Pfizer<\/li>\n<li>Emergent BioSolutions<\/li>\n<li>CSL<\/li>\n<li>Others<\/li>\n<li>Key Geographical Regions<\/li>\n<li>North America<\/li>\n<li>Europe<\/li>\n<li>Asia Pacific<\/li>\n<li>Rest of the World<\/li>\n<\/ul>\n<p>Key companies covered in the <a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/preventive-vaccines\/318.html\">report<\/a><\/p>\n<ul>\n<li>Bio Farma<\/li>\n<li>Emergent BioSolutions<\/li>\n<li>GC Pharma<\/li>\n<li>GlaxoSmithKline<\/li>\n<li>Janssen<\/li>\n<li>Merck<\/li>\n<li>Novavax<\/li>\n<li>Pfizer<\/li>\n<li>Sanofi Pasteur<\/li>\n<li>Valneva<\/li>\n<\/ul>\n<p>For more information please click on the following link:<\/p>\n<p><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/preventive-vaccines\/318.html\">https:\/\/www.rootsanalysis.com\/reports\/view_document\/preventive-vaccines\/318.html<\/a><\/p>\n<p><strong>Other Recent Offerings<\/strong><\/p>\n<p><strong>About Roots Analysis<\/strong><\/p>\n<p>Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you\u2019d like help with your growing business needs, get in touch at info@rootsanalysis.com<\/p>\n<p><strong>Contact Information<\/strong><\/p>\n<p>Roots Analysis Private Limited<\/p>\n<p>Gaurav Chaudhary<\/p>\n<p>+1 (415) 800 3415<\/p>\n<p>gaurav.chaudhary@rootsanalysis.com<\/p>\n<div id=\"related_posts_wrap\">\n<h4>Also Read:<\/h4>\n<\/p>\n<\/div>\n<p><h3> Contact Information: <\/h3>\n<\/p>\n<p>Contact:<br \/>Gaurav Chaudhary<br \/>gaurav.chaudhary@rootsanalysis.com<\/p>\n<p>Roots Analysis<br \/>A430, 4th Floor,<br \/>Bestech Business Towers, Sector 66, Mohali, India<br \/>sales@rootsanalysis.com<br \/>+1 (415) 800 3415<br \/>+44 (122) 391 1091<br \/>Web: https:\/\/www.rootsanalysis.com\/<br \/>LinkedIn: https:\/\/in.linkedin.com\/company\/roots-analysis<br \/>Twitter: https:\/\/twitter.com\/RootsAnalysis <\/p>\n<hr>\n<div class=\"viacrowd viaimg\"> <a href=\"https:\/\/icrowdnewswire.com\"><img decoding=\"async\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/themes\/icrowdnewswire\/images\/post_via_image.png\" alt=\"iCrowdNewswire\"><\/a> <\/div>\n<p> <!-- Now display keyword(tags) if any, and Categories combined --> <\/p>\n<p><span id=\"keywords_post_single\"> <strong> Keywords:<\/strong>&nbsp;&nbsp;&nbsp;&nbsp;preventive vaccines, influenza vaccine, bcg vaccine, chickenpox vaccine, mmr vaccine, Roots Analysis, Research, Biotech, Analysis, Report, Market Research, Market Report,<\/span><\/p>\n<p> <!--<\/p>\n\n\n\n\n\n\n\n<p>\n\n\n\n<div class=\"btn btn-primary\"> <a href=\"\" target=\"_blank\" id=\"related_posts_url\" rel=\"noopener noreferrer\">View Related Posts<\/a> <\/div>\n\n\n\n--> <\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis\/\">The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>iCrowdNewswire &nbsp;&nbsp;Jan 21, 2021&nbsp;&nbsp;2:10 PM ET Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;Global [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis\/\">The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-100843","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis - Business\" \/>\n<meta property=\"og:description\" content=\"iCrowdNewswire &nbsp;&nbsp;Jan 21, 2021&nbsp;&nbsp;2:10 PM ET Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;Global [&hellip;] The post The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-21T19:10:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/\",\"url\":\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/\",\"name\":\"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#primaryimage\"},\"image\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png\",\"datePublished\":\"2021-01-21T19:10:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/","og_locale":"en_US","og_type":"article","og_title":"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis - Business","og_description":"iCrowdNewswire &nbsp;&nbsp;Jan 21, 2021&nbsp;&nbsp;2:10 PM ET Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list Roots Analysis is pleased to announce the publication of its recent study, titled, &ldquo;Global [&hellip;] The post The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/","og_site_name":"Business","article_published_time":"2021-01-21T19:10:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/","url":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/","name":"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#primaryimage"},"image":{"@id":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png","datePublished":"2021-01-21T19:10:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/01\/4671-1611208033.png"},{"@type":"BreadcrumbList","@id":"http:\/\/ipsnews.net\/business\/2021\/01\/21\/the-global-preventive-vaccines-market-is-projected-to-be-worth-usd-94-billion-by-2030-growing-at-a-cagr-of-10-7-claims-roots-analysis-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"The global preventive vaccines market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/100843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=100843"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/100843\/revisions"}],"predecessor-version":[{"id":100844,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/100843\/revisions\/100844"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=100843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=100843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=100843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}